Deadline: 15 March 2024
GenScript Life Science Research Grant Program is a new initiative dedicated to supporting breakthroughs in life science research areas including but not limited to:
- Gene and Cell Therapy Development
- Antibody Drug Discovery
- Vaccine Development
- Diagnostics
- Plant Sciences
This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.
How it Works
- GenScript provides comprehensive “one-stop” solutions for projects in the identified research areas through its advanced technologies and platforms. The Life Science Research Grant Program will leverage GenScript’s existing capabilities to accelerate projects by partnering with investigators globally on their proposed projects.
- A total of 40 grants are planned and will be awarded based on scientific merit, potential for impact, and strategic alignment with GenScript’s primary areas of scientific interest.
- Grants will be awarded at a range of funding levels, dependent on GenScript’s internal committee assessment of the project’s budget needs.
- The maximum amount to be awarded is set at 100,000 USD for qualifying projects. Projects are expected to commence within six (6) months of receiving grant funding from GenScript, and research activities should generally take place over one year or less.
Criteria
Global eligibility Universities/Institutes/Biotechs
- Complete application in the portal
- Project Scope
- Research Significance
- Key Innovations
- Timeline
- Budget Breakdown
- GenScript Research Grant Committee
- Decisions are communicated in 4 to 8 weeks after the submission
- Award announcement
- Projects commence within 6 months of award
- A contract is established
- Sign the agreement and spend your award funds on GenScript services within 12 months.
For more information, visit GenScript.